Research Square (Research Square),
Journal Year:
2023,
Volume and Issue:
unknown
Published: June 8, 2023
Abstract
Background
The
relationship
between
N6-methyladenosine
(m6A)
regulators
and
anoikis
their
effects
on
low-grade
glioma
(LGG)
are
not
clear
yet.
Methods
TCGA-LGG
cohort,
mRNAseq
325
dataset
GSE16011
validation
set
were
separately
gained
via
Cancer
Genome
Atlas
(TCGA),
Chinese
Glioma
Altas
(CGGA)
Gene
Expression
Omnibus
(GEO)
databases.
27
m6A-related
genes
(m6A-RGs)
508
anoikis-related
(ANRGs)
extracted
from
published
articles,
individually.
First,
differentially
expressed
(DEGs)
LGG
Normal
samples
sifted
out
by
differential
expression
analysis.
DEGs
respectively
intersected
with
m6A-RGs
ANRGs
to
acquire
(DE-m6A-RGs)
(DE-ANRGs).
Correlation
analysis
of
DE-m6A-RGs
DE-ANRGs
was
performed
obtain
DE-m6A-ANRGs.
Next,
univariate
Cox
least
absolute
shrinkage
selection
operator
(LASSO)
DE-m6A-ANRGs
sift
risk
model
genes,
score
according
them,
then
gene
enrichment
(GSEA)
implemented
based
genes.
After
that,
we
constructed
an
independent
prognostic
model,
immune
infiltration
drug
sensitivity
Finally,
mRNA-miRNA-lncRNA
regulatory
network
constructed.
Results
There
6901
samples.
six
214
through
intersecting
ANRGs,
respectively.
149
derived
after
correlation
4
namely
ANXA5,
KIF18A,
BRCA1
HOXA10
composed
the
they
involved
in
apoptosis,
fatty
acid
metabolism
glycolysis,
etc..
age
finally
construct
model.
Activated
CD4
T
cell,
gamma
delta
cell
natural
killer
had
largest
positive
while
activated
B
significantly
negatively
correlated
KIF18A
BRCA1.
AT.9283,
EXEL.2280,
Gilteritinib
Pracinostat
(Absolute
value)
score.
(mRNAs)_,
12
miRNAs
21
lncRNAs
formed
network,
containing
HOXA10-hsa-miR-129-5p-LINC00689,
KIF18A-hsa-miR-
221-3p-DANCR,
Conclusion
Through
bioinformatics,
a
m6A-associated
LGG,
providing
new
ideas
for
research
related
prognosis
treatment
LGG.
Biomedicine & Pharmacotherapy,
Journal Year:
2022,
Volume and Issue:
154, P. 113609 - 113609
Published: Aug. 27, 2022
Epigenetic
factors
are
critical
regulators
of
biological
and
pathological
mechanisms
they
could
interact
with
different
molecular
pathways.
Targeting
epigenetic
has
been
an
idea
approach
in
disease
therapy,
especially
cancer.
Accumulating
evidence
highlighted
function
long
non-coding
RNAs
(lncRNAs)
as
cancer
initiation
development
focused
on
their
association
downstream
targets.
microRNAs
(miRNAs)
the
most
well-known
targets
lncRNAs
present
review
focuses
lncRNA-miRNA
axis
malignancy
therapy
resistance
tumors.
LncRNA-miRNA
regulates
cell
death
such
apoptosis
autophagy
cancers.
This
affects
tumor
metastasis
via
regulating
EMT
MMPs.
Besides,
determines
sensitivity
cells
to
chemotherapy,
radiotherapy
immunotherapy.
Based
studies,
can
be
affected
by
drugs
genetic
tools
this
may
affect
expression
level
miRNAs
targets,
leading
suppression/progression.
LncRNAs
have
both
tumor-promoting
tumor-suppressor
functions
unique
complicated
implication
therapy.
also
other
signaling
networks
PI3K/Akt,
STAT3,
Wnt/β-catenin
EZH2
among
others.
Notably,
lncRNA/miRNA
considered
a
signature
for
diagnosis
prognosis
Frontiers in Oncology,
Journal Year:
2025,
Volume and Issue:
14
Published: Jan. 16, 2025
Multiple
Myeloma
(MM)
is
the
second
most
common
malignancy
of
hematopoietic
system,
accounting
for
approximately
10%
all
hematological
malignancies,
and
currently,
there
no
complete
cure.
Existing
research
indicates
that
exosomal
long
non-coding
RNAs
(lncRNAs)
play
a
crucial
regulatory
role
in
initiation
progression
tumors,
involving
various
interactions
such
as
lncRNA-miRNA,
lncRNA-mRNA,
lncRNA-RNA
binding
proteins
(RBP).
Despite
significant
clinical
application
potential
lncRNAs,
this
area
still
faces
challenges
due
to
their
low
abundance
technical
limitations.
To
our
knowledge,
review
first
comprehensively
integrate
elucidate
three
mechanisms
action
lncRNAs
MM,
propose
therapeutic
targets
cases
based
on
these
mechanisms.
We
highlight
latest
advancements
biomarkers
targets,
offering
not
only
comprehensive
analysis
MM
but
also
new
perspectives
methods
future
diagnosis
treatment
multiple
myeloma.
Non-coding RNA Research,
Journal Year:
2024,
Volume and Issue:
9(4), P. 1315 - 1323
Published: July 1, 2024
This
review
article
studies
the
complex
field
of
noncoding
RNAs
(ncRNAs)
in
cancer
biology,
focusing
on
their
potential
use
as
biomarkers
and
therapeutic
targets.
NcRNAs
include
circular
(circRNAs),
long
(lncRNAs),
microRNAs
(miRNAs).
We
discuss
how
ncRNAs
affect
gene
expression
cancerous
cells,
spread
cancer,
metastasis.
The
illustrates
pathways
through
which
can
oncogenesis,
tumor
suppression,
resistance.
It
also
assesses
clinical
uses
non-coding
(ncRNAs),
including
utility
diagnosis,
prognosis.
Besides,
for
personalized
therapy
is
documented.
Finally,
it
concluded
that
understanding
role
ncRNA
importance
regarding
carcinogenesis,
therapy.
Aging,
Journal Year:
2022,
Volume and Issue:
14(1), P. 509 - 525
Published: Jan. 12, 2022
Long
noncoding
RNAs
(lncRNAs)
have
been
reported
to
exhibit
a
crucial
regulatory
role
in
tumor
progression,
including
cholangiocarcinoma
(CCA).
As
promising
lncRNA,
proteasome
20S
subunit
alpha
3
antisense
RNA
1
(PSMA3-AS1)
is
involved
development
of
various
tumors.
However,
the
and
function
PSMA3-AS1
CCA
remain
unclear.
The
aim
this
study
examine
expression,
function,
mechanism,
clinical
significance
development.
By
TCGA
database
analysis,
we
found
that
was
overexpressed
CCA.
Consistent
with
significantly
tissues
cells
by
RT-qPCR.
Upregulated
related
lymph
node
invasion,
advanced
TNM
stage
poor
survival,
an
independent
risk
factor
prognosis
for
patients.
Functionally,
CCK-8,
EdU
colony
formation
assays
confirmed
upregulated
promoted
cell
proliferation,
whereas
downregulated
inhibited
proliferation.
This
result
further
subcutaneous
nude
mice.
Wound
healing
transwell
increased
migration
decreased
these
biological
phenotypes.
In
addition,
EMT
process
downregulating
E-cadherin
upregulating
N-cadherin
vimentin.
Mechanistically,
transcription
PAX5
bound
promoter
region
its
transcription.
Simultaneously,
primarily
localized
cytoplasm
could
competitively
bind
miR-376a-3p
upregulate
LAMC1,
thereby
accelerating
progression.
uncovers
functions
as
cancer-promoting
gene
CCA,
PAX5/PSMA3-AS1/miR-376a-3p/LAMC1
axis
plays
vital
Biology Direct,
Journal Year:
2023,
Volume and Issue:
18(1)
Published: July 4, 2023
Abstract
LncRNA
PSMA3-AS1
functions
as
an
oncogene
in
several
cancers,
including
ovarian
cancer,
lung
and
colorectal
cancer.
However,
its
role
gastric
cancer
(GC)
progression
remains
unclear.
In
this
study,
the
levels
of
PSMA3-AS1,
miR-329-3p,
aldolase
A
(ALDOA)
20
paired
human
GC
tissues
adjacent
nontumorous
were
measured
by
real-time
PCR.
cells
transfected
with
recombinant
plasmid
carrying
full-length
or
shRNA
targeting
PSMA3-AS1.
The
stable
transfectants
selected
G418.
Then,
effects
knockdown
overexpression
on
vitro
vivo
evaluated.
results
showed
that
was
highly
expressed
tissues.
Stable
significantly
restrained
proliferation/migration/invasion,
enhanced
cell
apoptosis,
induced
oxidative
stress
vitro.
Tumor
growth
matrix
metalloproteinase
expression
tumor
markedly
inhibited,
while
nude
mice
after
knockdown.
Additionally,
negatively
regulated
miR-329-3p
positively
ALDOA
expression.
MiR-329-3p
directly
targeted
ALDOA-3′UTR.
Interestingly,
partially
attenuated
tumor-suppressive
Conversely,
exhibited
opposite
effects.
promoted
regulating
miR-329-3p/ALDOA
axis.
might
serve
a
promising
effective
target
for
treatment.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(2), P. 694 - 694
Published: Jan. 15, 2025
Long
non-coding
RNAs
(lncRNAs)
play
a
pivotal
role
in
regulating
gene
expression
and
are
critically
involved
the
progression
of
malignant
brain
tumors,
including
glioblastoma,
medulloblastoma,
meningioma.
These
lncRNAs
interact
with
microRNAs
(miRNAs),
proteins,
DNA,
influencing
key
processes
such
as
cell
proliferation,
migration,
invasion.
This
review
highlights
multifaceted
impact
lncRNA
dysregulation
on
tumor
underscores
their
potential
therapeutic
targets
to
enhance
efficacy
chemotherapy,
radiotherapy,
immunotherapy.
The
insights
provided
offer
new
directions
for
advancing
basic
research
clinical
applications
tumors.
Biomedicine & Pharmacotherapy,
Journal Year:
2022,
Volume and Issue:
149, P. 112896 - 112896
Published: March 29, 2022
MiRNA
accounts
for
1-3%
of
genes
but
regulates
more
than
30%
gene
expression
in
humans.
This
article
analyzes
the
current
deficiencies
and
challenges
miR-411
research
looks
forward
to
prospects
cancer.
MiR-411
is
a
non-coding
RNA
located
on
chromosome
14.
abnormally
expressed
variety
cancers.
The
dysregulation
can
affect
cancer
cell
proliferation,
invasion,
migration,
apoptosis,
colony
formation,
etc.
be
regulated
by
different
lncRNAs
circRNAs.
By
targeting
multiple
genes,
participates
activation
MAPK
signaling
pathway,
PI3K/AKT/mTOR
p53
Ras
NF-κB
Wnt/β-catenin
pathway.
related
diagnosis,
prognosis,
sensitivity
drugs
patients.
In
conclusion,
this
work
outlines
molecular
mechanisms
cellular
functions
aberrant
its
target
reveal
potential
value
drug
sensitivity.
BMC Genomics,
Journal Year:
2023,
Volume and Issue:
24(1)
Published: Feb. 8, 2023
Ischemic
stroke
(IS)
is
a
serious
neurological
disease
that
largely
results
in
long-term
disability
and
death.
Extensive
evidence
has
indicated
the
activation
of
inflammation
ferroptosis
significantly
contribute
to
development
IS
pathology.
However,
underlying
molecular
mechanism
remains
unclear.
In
this
study,
we
aimed
identify
potential
biomarkers
associated
with
through
construction
competing
endogenous
RNA
(ceRNA)
network
investigate
possible
inflammatory
ferroptosis-related
mechanisms.We
identified
178
differentially
expressed
target
messenger
RNAs
(DETmRNAs)
IS.
As
revealed
enrichment
analysis,
DEmRNAs
were
mainly
enriched
signaling
pathways
also
related
mechanism.
The
CIBERSORT
algorithm
showed
immune
infiltration
landscapes
which
naïve
B
cells,
T
monocytes
had
statistically
different
numbers
cerebral
infarction
group
compared
control
group.
A
ceRNA
was
constructed
study
involving
44
long
non-coding
(lncRNAs),
15
microRNAs
(miRNAs),
160
(mRNAs).
We
used
receiver
operating
characteristic
(ROC)
analysis
three
miRNAs
(miR-103a-3p,
miR-140-3p,
miR-17-5p),
one
mRNA
(TLR4),
lncRNA
(NEAT1)
as
key
network.
shown
be
highly
expression
these
further
validated
by
method
quantitative
real-time
polymerase
chain
reaction
SH-SY5Y
consistent
findings
predicted
bioinformatics.Our
suggest
may
exert
an
important
role
mechanisms
IS,
providing
new
insight
into
therapeutic
targets.